Brian Hullinger - Aug 17, 2023 Form 4 Insider Report for PSYCHEMEDICS CORP (PMD)

Role
President & CEO, Director
Signature
Patrick J. Kinney, Jr. as attorney-in-fact for Brian Hullinger
Stock symbol
PMD
Transactions as of
Aug 17, 2023
Transactions value $
$0
Form type
4
Date filed
8/21/2023, 05:48 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMD Stock Option (Right to Buy) Award $0 +100K $0.00 100K Aug 17, 2023 Common Stock, $.005 Par Value 100K $4.64 Direct F1
transaction PMD Stock Option (Right to Buy) Award $0 +200K $0.00 200K Aug 17, 2023 Common Stock, $.005 Par Value 200K $4.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable with respect to 50% of the shares on August 17, 2024 and with respect to the remaining 50% on August 17, 2025.
F2 The option becomes exercisable, if at all, in two 100,000 share increments if the weighted average daily price of Psychemedics Corporation's common stock on the Nasdaq Stock Market during any 60 consecutive calendar day period exceeds $5.50 and $6.50, respectively.